Haemonetics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
125 Summer St, Boston, Massachusetts, 02...Phone Number
(781) 848-7100Website
www.haemonetics.comRevenue
$1.4 BillionStock Symbol
HAEIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
2
2
2
1
About Haemonetics
Haemonetics is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Our legacy of innovation was built on a dynamic approach to product development and customer support, an entrepreneurial-minded culture, and an unwavering commitment to quality, integrity and "making it matter" to patients around the world.Explore more
Haemonetics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Haemonetics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Haemonetics recently announced quarterly report
Click to see if Haemonetics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Haemonetics
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Haemonetics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Haemonetics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Haemonetics launches new products
Haemonetics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Haemonetics is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Haemonetics
Compare insights from companies similar to Haemonetics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$271.6M
1K - 5K
Private
-
1964
Company Profile Activity
Activity Insights
Haemonetics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Haemonetics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Haemonetics.
Haemonetics financials insights
Gather financial insights about Haemonetics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Debt
$730M
Haemonetics Tech Stack
A closer look at the technologies used by Haemonetics
Most Recent Scoops
Open Position
Open Position
Open Position
Person-Based
Compensation & Benefits, HR Operations, Organizational Development
Person-Based
Earnings, Finance
Haemonetics News & Media
Haemonetics Q1 Earnings Call Highlights
Haemonetics (NYSE:HAE) reported a stronger start to fiscal 2027, with first-quarter revenue rising 6% year over year to $339 million and adjusted diluted earnings per share increasing 4% to $1.14. The company raised its full-year revenue outlook, citing broad-based growth across its MedSurg and apheHaemonetics Corporation (HAE) Q1 2027 Earnings Call Transcript
Haemonetics Corporation (HAE) Q1 2027 Earnings Call August 6, 2026 8:00 AM EDTCompany ParticipantsOlga Guyette - VP of IR & TreasuryChristopher Simon -...Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website
Financial release and supplemental presentation accessible online BOSTON, Aug. 6, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2027, which ended June 27, 2026, are available on the Company's Investor Relations...New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths
BOSTON, Aug. 3, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced publication of a study providing new evidence supporting the safety and efficacy...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Haemonetics
Sign Up For FreeTo access detailed company insights
Haemonetics is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Ou... Read More
